drugset / Trial / NCT01140984

Intra Arterial (IA) Steroids Infusion for Hepatic Acute Hepatic Graft Versus Host Disease (aGVHD)

NCT01140984

Terminated 2 enrolled Hadassah Medical Organization
NaSingle-groupOpen-labelTreatment

Summary

Post allogeneic hematopoietic stem cell transplantation (HSCT) patients with steroid resistant acute GVHD localised to the liver will receive 24 hours continuous intra-arterial infusion of methylprednisolone.

Timeline

Start
2010-09
Primary completion
2015-03
Completion
2015-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 600 mg/m2 Other